Kajdácsi Erika, Jani Péter K, Csuka Dorottya, Varga Lilian, Prohászka Zoltán, Farkas Henriette, Cervenak László
3rd Department of Internal Medicine, Semmelweis University, Kútvölgyi út 4., Budapest, H-1125, Hungary.
J Clin Immunol. 2016 Feb;36(2):160-70. doi: 10.1007/s10875-016-0239-8. Epub 2016 Feb 12.
The elevation of bradykinin (BK) level during attacks of hereditary angioedema due to C1-Inhibitor deficiency (C1-INH-HAE) is well known. We previously demonstrated that endothelin-1 (ET-1) level also increases during C1-INH-HAE attacks. Although BK and ET-1 are both potent vasoactive peptides, the vasoregulatory aspect of the pathomechanism of C1-INH-HAE has not yet been investigated. Hence we studied the levels of vasoactive peptides in controls and in C1-INH-HAE patients, as well as evaluated their changes during C1-INH-HAE attacks. The levels of arginine vasopressin (AVP), adrenomedullin (ADM) and ET-1 were measured in the plasma of 100 C1-INH-HAE patients in inter-attack periods and of 111 control subjects, using BRAHMS Kryptor technologies. In 18 of the 100 C1-INH-HAE patients, the levels of vasoactive peptides were compared in blood samples obtained during attacks, or in inter-attack periods. AVP, ADM and ET-1 levels were similar in inter-attack samples from C1-INH-HAE patients and in the samples of controls, although cardiovascular risk has an effect on the levels of vasoactive peptides in both groups. The levels of all three vasoactive peptides increased during C1-INH-HAE attacks. Moreover, the levels of ET-1 and ADM as well as their changes during attacks were significantly correlated. This study demonstrated that vascular regulation by vasoactive peptides is affected during C1-INH-HAE attacks. Our results suggest that the cooperation of several vasoactive peptides may be necessary to counterbalance the actions of excess BK, and to terminate the attacks. This may reveal a novel pathophysiological aspect of C1-INH-HAE.
由于C1抑制剂缺乏导致的遗传性血管性水肿(C1-INH-HAE)发作期间缓激肽(BK)水平升高是众所周知的。我们之前证明,内皮素-1(ET-1)水平在C1-INH-HAE发作期间也会升高。虽然BK和ET-1都是有效的血管活性肽,但C1-INH-HAE发病机制中的血管调节方面尚未得到研究。因此,我们研究了对照组和C1-INH-HAE患者中血管活性肽的水平,并评估了它们在C1-INH-HAE发作期间的变化。使用BRAHMS Kryptor技术,在100例C1-INH-HAE患者发作间期的血浆和111例对照受试者的血浆中测量了精氨酸加压素(AVP)、肾上腺髓质素(ADM)和ET-1的水平。在100例C1-INH-HAE患者中的18例中,比较了发作期间或发作间期采集的血样中血管活性肽的水平。C1-INH-HAE患者发作间期样本和对照样本中的AVP、ADM和ET-1水平相似,尽管心血管风险对两组血管活性肽水平都有影响。在C1-INH-HAE发作期间,所有三种血管活性肽的水平都升高。此外,ET-1和ADM的水平及其在发作期间的变化显著相关。这项研究表明,C1-INH-HAE发作期间血管活性肽的血管调节受到影响。我们的结果表明,可能需要几种血管活性肽的协同作用来抵消过量BK的作用,并终止发作。这可能揭示了C1-INH-HAE一个新的病理生理学方面。